 |
|||||||||||||||
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
|
|||||||||||||||
What's New
Avalere Study Shows That Patients with Medicare Part D Have More Access Barriers to Anticonvulsant Therapy Than Those Commercially Insured
05.20.13
Matt Eyles Joins Avalere Team as Executive Vice President
» View Upcoming Events
» Sign up for email alerts
Avalere′s Tweets
Solutions /
Vantage Care Positioning System™ /
Get unparalleled visibility on referral patterns and rehospitalizations by facility.
Avalere EBM Navigator™ /
Determine the impact of CER on your product portfolio with access to latest research.
Expert Webinars /
Complimentary Webinar: Life Sciences Strategies to Prepare for the Shifting Provider Landscape /
June 19 / 1:00-2:00 pm EST
Join Avalere Health and CHI for a complimentary webinar as we identify ways to prepare your organization for this new environment.
Spotlight On /
Review the Research / Medication Adherence
Learn the latest research on medication adherence efforts to contain costs and improve care quality.
Dig Deeper / Specialty Pharmacy
Join Sharon Siler June 18 on a SPAARx webinar on the HI-TECH/HIPAA Omnibus Final Rule's impact on specialty pharmacy stakeholders.
Prepare for Market Changes / Industry Perspectives
Join Eric Hammelman June 20 at AGC Chicago Healthcare M&A Conference.
Follow the Data / Young Adults and Rate Shock
An Avalere analysis found that most young adults enrolling in the exchange will be eligible for subsidies.
Know the Trends / State ACA Implementation
See our latest nationwide exchange activity and Medicaid expansion maps.
